As of November 2024, Paradigm Biopharmaceuticals has a market cap of $46.05M. This makes Paradigm Biopharmaceuticals the world's 24580th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $70.55M | -15.29% |
2023 | $83.29M | -69.75% |
2022 | $275.35M | -25.46% |
2021 | $369.42M | -26.08% |
2020 | $499.74M | -12.97% |
2019 | $574.21M | 185.73% |
2018 | $200.96M | 275.00% |
2017 | $53.59M | -28.21% |
2016 | $74.64M | 18.18% |
2015 | $63.16M | - |